KO vs PFE: Which Is the Better Buy?

Side-by-side comparison of The Coca-Cola Company and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-05.

The Coca-Cola Company · Consumer Defensive

$78.19

-7.8% upside to fair value

Grade D High Quality

PFE

Pfizer Inc. · Healthcare

$26.33

+35.4% upside to fair value

Grade B

QuantHub Verdict

PFE has more upside to fair value (+35.4%). PFE trades at a lower forward P/E (19.3x). These are model outputs — not personalized investment advice. See all research →

Valuation & Fundamentals

Metric	KO	PFE
Current Price	$78.19	$26.33
Fair Value Estimate	$72.12	$35.65
Upside to Fair Value	-7.8%	+35.4%
Market Cap	$336.5B	$149.8B
Forward P/E	24.6x	19.3x
EV / EBITDA	19.9x	12.9x
Price / Sales	6.8x	2.4x
Price / FCF	26.8x	16.5x
Revenue Growth YoY	+12.1%	-1.2%
Gross Margin	61.7%	70.3%
Operating Margin	29.3%	24.7%
Return on Equity	43.6%	8.7%
Dividend Yield	0%	0%
FCF Yield	3.73%	6.06%
Analyst Consensus	Strong Buy	Hold

Investment Thesis

KO — The Coca-Cola Company

The Coca-Cola Company is a leading global beverage company specializing in non-alcoholic drinks with a diversified portfolio including sparkling soft drinks, juices, water, coffee, and energy beverages. The business quality is high due to its durable brand moat, consistent earnings growth, and strong operational efficiency, reflected in a 43.6% return on equity and 12.1% revenue growth in the mos…

PFE — Pfizer Inc.

Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…

Accumulation Zones

Metric	KO	PFE
Zone Low	$54.09	$26.74
Zone High	$61.30	$30.30
In Buy Zone?	No	Yes

← KO Research PFE Research → All Research